Page last updated: 2024-09-04

isovitexin and galactosamine

isovitexin has been researched along with galactosamine in 1 studies

Compound Research Comparison

Studies
(isovitexin)
Trials
(isovitexin)
Recent Studies (post-2010)
(isovitexin)
Studies
(galactosamine)
Trials
(galactosamine)
Recent Studies (post-2010) (galactosamine)
1230813,5427704

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, JJ; Lin, MX; Pan, CW; Wang, H1

Other Studies

1 other study(ies) available for isovitexin and galactosamine

ArticleYear
Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
    Microbial pathogenesis, 2018, Volume: 119

    Topics: Animals; Apigenin; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Gene Expression Regulation; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Function Tests; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oryza; Phosphorylation; Plant Extracts; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation

2018